1. Home
  2. CRSP vs HRI Comparison

CRSP vs HRI Comparison

Compare CRSP & HRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRSP
  • HRI
  • Stock Information
  • Founded
  • CRSP 2013
  • HRI 1965
  • Country
  • CRSP Switzerland
  • HRI United States
  • Employees
  • CRSP N/A
  • HRI N/A
  • Industry
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • HRI Misc Corporate Leasing Services
  • Sector
  • CRSP Health Care
  • HRI Industrials
  • Exchange
  • CRSP Nasdaq
  • HRI Nasdaq
  • Market Cap
  • CRSP 3.4B
  • HRI 3.4B
  • IPO Year
  • CRSP 2016
  • HRI N/A
  • Fundamental
  • Price
  • CRSP $37.77
  • HRI $117.66
  • Analyst Decision
  • CRSP Buy
  • HRI Buy
  • Analyst Count
  • CRSP 19
  • HRI 5
  • Target Price
  • CRSP $74.35
  • HRI $177.20
  • AVG Volume (30 Days)
  • CRSP 2.4M
  • HRI 578.0K
  • Earning Date
  • CRSP 05-07-2025
  • HRI 04-22-2025
  • Dividend Yield
  • CRSP N/A
  • HRI 2.38%
  • EPS Growth
  • CRSP N/A
  • HRI N/A
  • EPS
  • CRSP N/A
  • HRI 7.40
  • Revenue
  • CRSP $37,314,000.00
  • HRI $3,568,000,000.00
  • Revenue This Year
  • CRSP $51.35
  • HRI $3.84
  • Revenue Next Year
  • CRSP $282.16
  • HRI $5.83
  • P/E Ratio
  • CRSP N/A
  • HRI $15.90
  • Revenue Growth
  • CRSP N/A
  • HRI 8.71
  • 52 Week Low
  • CRSP $30.04
  • HRI $109.39
  • 52 Week High
  • CRSP $67.88
  • HRI $246.88
  • Technical
  • Relative Strength Index (RSI)
  • CRSP 49.46
  • HRI 40.09
  • Support Level
  • CRSP $36.74
  • HRI $112.91
  • Resistance Level
  • CRSP $40.13
  • HRI $120.52
  • Average True Range (ATR)
  • CRSP 2.67
  • HRI 9.99
  • MACD
  • CRSP 0.72
  • HRI 0.00
  • Stochastic Oscillator
  • CRSP 76.62
  • HRI 25.05

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About HRI Herc Holdings Inc.

Herc Holdings Inc is an equipment rental company that was spun out of Hertz Global in 2016. It is currently the equipment rental company (4% market share) in North America, after United Rentals and Sunbelt Rentals, with a fleet size of $6.4 billion. It serves commercial and residential construction customers, the environmental sector, industrial entities, and entertainment production companies. During much of its 50-year-plus history, the company has rented equipment such as aerial lifts to its customers for intermittent use. More recently, it has broadened its catalog to include a host of specialty items. Separately, Herc Holdings' prepares now to incorporate long-term rentals to industrial customers where Herc maintains its own staff at the customer site.

Share on Social Networks: